Neogenomics (NEO) PT Raised to $22 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall St set for steady open as oil jumps ahead of key earnings
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $16.19 -0.98%
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Join SI Premium – FREE
TD Cowen analyst Dan Brennan raised the price target on Neogenomics (NASDAQ: NEO) to $22.00 (from $20.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $220 at BMO Capital
- Neogenomics (NEO) PT Raised to $20 at StoneX
- Alibaba (9988:HK) (BABA) PT Raised to HK$195.70 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
